The fusion protein BRD4-NUT is responsible for the aggressive NUT midline carcinoma [13], while interaction of BRD4 with acetylated NF-κB/RelA leads to constitutively active NF-κB, enhancing cancer cell proliferation [14]. The gene discussed is BRD4; the disease is cancer.